Clinical trial

If Channel Blockade With Ivabradine in Patients With Diastolic Heart Failure

NCT00757055

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Ivabradine Normalized identity: ivabradineView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

If Channel Blockade With Ivabradine in Patients With Diastolic Heart Failure

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2012-12-01

PhasePHASE2

Conditions

Diastolic Heart Failureverified · MONDO: diastolic heart failure

Interventions

IvabradineDRUG · verified · RxNorm: ivabradine

PlaceboDRUG

Sponsors & collaborators

St Vincent's University Hospital, Irelandlead sponsor

Mapped research locations

DublinIreland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00757055 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.